The Hidden Impact of Motor Neurone Disease on Everyday Life

Motor neurone disease (MND) can develop with simple discomforts that often go unnoticed. For instance, early symptoms of MND involve difficulty lifting the foot on stairs, fingers unable to perform simple tasks, or slurred speech. With time, the change becomes prominent. Performing everyday tasks like breathing, communication, foot intake, and maintaining independence becomes difficult. The condition gets challenging, and the effects extend far beyond muscle weakness. MND damages the motor neurons responsible for controlling voluntary muscles. As these nerve cells progressively degenerate, the brain and spinal cord lose their ability to communicate effectively with muscles. Amyotrophic lateral sclerosis (ALS) is the most common clinical form of MND that affects breathing and cognitive or behavioural functions.

The current conventional treatments focus on symptom management and slowing disease progression. However, they do not address the underlying cause. Researchers and clinicians are actively focusing on regenerative medicine in Motor Neurone Disease. ALS stem cell therapy examines whether cell-based approaches potentially protect the vulnerable neurons or modify the disease environment. The current article focuses on understanding both the daily realities of MND and the limits and possibilities of emerging research to gain a balanced perspective on the road ahead.

Ask The Expert

What Happens in MND at the Cellular Level?

Motor neuron disease accounts for muscle weakness that gets worse over time. The condition develops rapidly in the majority of patients and has no proven cure. The key changes at the cellular level involve: 

• Protein Aggregation: Abnormal accumulation of certain proteins (TDP-43). This interferes with normal neuronal function and survival
• Mitochondrial Dysfunction: Impaired energy production and increase in oxidative stress create immense stress on motor neurons. This significantly increases the energy demands
• Glutamate Excitotoxicity: Upregulated glutamate signalling overstimulates neurons. This significantly increases calcium influx and leads to cellular injury
• Neuroinflammation: Chronic low-grade inflammation in microglia and astrocytes leads to altered responses
• Impaired Communication: Damage to the transportation system and nerve fibres disrupts communication between motor neurons and muscles
• Neuromuscular Junction Dysfunction: Deterioration between motor neuron and muscle fibers reduces nerve-to-muscle signalling
• Muscular Deterioration: Muscles receive limited signals. The progressive symptoms include muscle weakness, spasm, wasting, and decline of physical function

*NOTE: It is crucial to understand the different forms of MND, including ALS. Among ALS patients, both upper and lower motor neurons are affected significantly. 

What are the Early Symptoms of MND? 

Early Symptoms of Motor Neurone Disease often go unnoticed. The key challenges include: 

• Altered Movement: Muscle weakness, cramps, stiffness in upper/lower limbs, occasional muscle twitching, etc.
• Difficulty with fine Motor Use: Challenges in writing, gripping, picking objects, etc. 
• Speech and Swallowing Changes: Slurred speech, challenge in articulating words or phrases, swallowing difficulties, etc.
• Mobility Challenges: Sudden fall, tripping, inability to climb stairs, etc. 

With a worsened health condition, the symptoms appear as:

• Significant breathing difficulties and swallowing difficulties
• Drooling with increased saliva production
• Changes in mood and personality
• Difficulty in walking or independent movement
• Changes in speech, inability to communicate, requires communication aid

What are the Current MND Treatments? 

Motor neurone disease treatment targets symptom management. A similar approach is introduced in ALS management. This includes:

Medication

• Baclofen introduced to combat muscle tightness, reduce muscle spasm
• Glycopyrrolate to reduce drooling
• Benzodiazepines for pain management
• Phenytoin/ Quinine for muscle cramps
• Antidepressants to manage psychological stress
• Riluzole and edaravone to slow down the neurodegenerative decline

Supportive Intervention

• Physiotherapy and regular exercise to gain muscle strength and relieve stiffness
• Dietary intervention to maintain healthy weight
• Introduction of supportive equipment that aids in eating or drinking
• Mobility equipment to help walk, move, etc.
• Aid in communication; speech therapist introduces suitable communication aid
• Cognitive behavioral therapy to cope with emotions, stress or depression
• Introduction of oxygen therapy to support breathlessness

What Is the Science Exploring in MND Management?

Regenerative medicine intends to support the biological signals along with symptom control. Stem cell treatment for ALS and other forms of MND is widely explored by researchers. Mesenchymal stem cells (MSCs) are explored due to their regenerative capacity and paracrine signalling. Stem cells undertake multiple mechanisms simultaneously, including:

Combat Neuronal Loss

• Normally, the central nervous system has limited regenerative capacity
• MSCs release various signalling molecules that create a supportive microenvironment
• It creates a more hospitable environment and supports cell survival
• The signalling molecules boost the repair signalling network 

Anti-Inflammation and Immunomodulation

• MSCs release various anti-inflammatory molecules that combat the action of inflammatory cytokines
• Calming neuroinflammation creates a supportive microenvironment
• It modulates immune response and supports regenerative action and conventional treatment

Neuroprotection

• MSCs potentially release neurotrophic factors that stimulate the neural environment
• They deliver protective signals, enhancing neuronal survival 
• Researchers widely explore ALS stem cell therapy and other MND forms due to their critical nature

What Does the Current Research Reveal?

• Preclinical and early clinical research have established a positive trend in introducing stem cells among motor neuron disease patients
• MSCs introduction displayed safety and tolerance; no significant side effects are reported
• The studies using glial restricted progenitor cells and neural progenitor cells displayed consistent growth factor production (GDNF) [1]
• Support of motor function among MND patients
• Future research focuses on launching well-structured large-scale clinical trials considering multiple parameters. This is crucial to establish long-term safety and efficacy of the treatment [2]
• Clinicians currently introduce stem cell treatment for ALS as a supportive effort with conventional treatment
• The key consideration involves stem cell quality, source, types, isolation procedure, administration route, and the individual’s overall health condition

*NOTE: Advancells, India is a leading manufacturer and supplier of well-characterized, clinical-grade stem cells for chronic health conditions including MND. The product comes with a Certificate of Authentication (CoA)

Conclusion 

Stem Cell Treatment for ALS is evolving and potentially an advanced solution to combat neurodegenerative conditions. Currently, stem cell therapy is progressive and is at an investigational stage. Currently, they act as a supportive intervention along with conventional treatment. The future focuses on rigorous large-scale clinical trials to establish long-term treatment efficacy, safety, and tolerability.

References

1. Baloh RH, Johnson JP, Avalos P, Allred P, Svendsen S, Gowing G, Roxas K, Wu A, Donahue B, Osborne S, Lawless G. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial. Nature medicine. 2022 Sep;28(9):1813-22. 
2. Ceccarelli L, Verriello L, Pauletto G, Valente M, Spadea L, Salati C, Zeppieri M, Ius T. The role of human pluripotent stem cells in amyotrophic lateral sclerosis: From biological mechanism to practical implications. FRONTIERS IN BIOSCIENCE. 2024;29(3):1-3. 

FAQ’s

Q- What are the early symptoms of MND?

Early symptoms of motor neurone disease often include muscle weakness, cramps, twitching, stiffness, slurred speech, or difficulty walking. The symptoms vary from person to person and may initially seem minor, but progressive changes need medical evaluation.

Q- How does MND affect everyday life activities?

MND significantly affects various everyday activities. This includes walking, dressing, swallowing, speaking, etc. With the progression of the condition, individuals experience breathing difficulties, fatigue, and psychological challenges. This affects independence and quality of life.

Q- Is stem cell treatment for ALS effective?

Researchers widely explore stem cell treatment for ALS to support motor neuron function by modulating inflammation and releasing protective signalling molecules. Early studies are exploring their safety and potential benefits. Further studies are required to establish the treatment’s long-term efficacy and safety. 

Q- Can ALS stem cell therapy repair damaged motor neurons?

ALS stem cell therapy targets protection and repair of the vulnerable neurons. They potentially create a supportive microenvironment. However, replacing lost motor neurons and restoring their functional connections remain a practical challenge. Researchers focus on launching large-scale clinical trials to improve outcomes.